ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
MRNA期權收益策略ETF-YieldMax
19.53
-0.0300
-0.15%
盤後:
19.50
-0.0300
-0.15%
19:43 EST
成交量:
14.70萬
成交額:
285.14萬
市值:
9,384.11萬
市盈率:
- -
高:
19.67
開:
19.34
低:
19.06
收:
19.56
52周最高:
38.45
52周最低:
13.60
股本:
480.50萬
流通股本:
480.50萬
量比:
0.77
換手率:
3.06%
股息:
18.59
股息率:
95.17%
淨資產收益率:
--
總資產收益率:
--
市淨率:
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
概念
沒有相關數據
資金流向
資金流入:
資金流出:
實時
日
周
月
季度
年
新聞資訊
BioNTech控告Moderna侵犯新冠疫苗專利
环球市场播报
·
02/20
異動解讀 | FDA立場轉變改善流感疫苗監管前景,Moderna盤中大漲5.06%
异动解读
·
02/20
異動解讀 | FDA同意審查流感疫苗,Moderna盤前大漲5.28%
异动解读
·
02/18
Moderna(MRNA.US):美國食品藥品監督管理局將啓動對其在研季節性流感疫苗申報的審查。
格隆汇
·
02/18
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MRNY"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"MRNY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNY\",,,,,undefined,":{"symbol":"MRNY","market":"US","secType":"STK","nameCN":"MRNA期權收益策略ETF-YieldMax","latestPrice":19.53,"timestamp":1771621200000,"preClose":19.56,"halted":0,"volume":147036,"hourTrading":{"tag":"盘后","latestPrice":19.5,"preClose":19.53,"latestTime":"19:43 EST","volume":3809,"amount":74116.368,"timestamp":1771634639006,"change":-0.03,"changeRate":-0.001536,"amplitude":0.006308},"delay":0,"changeRate":-0.0015337423312882202,"floatShares":4804974,"shares":4804974,"eps":0,"marketStatus":"休市中","change":-0.03,"latestTime":"02-20 16:00:00 EST","open":19.34,"high":19.67,"low":19.06,"amount":2851375.927176,"amplitude":0.031186,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"exchange":"ARCA","adjPreClose":19.56,"sharesOutstanding":4804974,"nav":19.55,"aum":93937241.7,"dividendRate":0.951749,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":19.43,"preClose":19.56,"latestTime":"09:29 EST","volume":1222,"amount":23664.957498,"timestamp":1771597743000,"change":-0.13,"changeRate":-0.006646,"amplitude":0.019427},"postHourTrading":{"tag":"盘后","latestPrice":19.5,"preClose":19.53,"latestTime":"19:43 EST","volume":3809,"amount":74116.368,"timestamp":1771634639006,"change":-0.03,"changeRate":-0.001536,"amplitude":0.006308},"volumeRatio":0.7683649117108615,"impliedVol":0.1198,"impliedVolPercentile":0.028},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MRNY\",,,,,undefined,":{"symbol":"MRNY","floatShares":4804974,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.7683649117108615,"shares":4804974,"dividePrice":18.587667,"high":19.67,"amplitude":0.031186,"preClose":19.56,"low":19.06,"week52Low":13.6,"pbRate":"--","week52High":38.45,"institutionHeld":0,"latestPrice":19.53,"eps":0,"divideRate":0.951749,"volume":147036,"delay":0,"ttmEps":0,"open":19.34,"prevYearClose":14.7,"prevWeekClose":17.75,"prevMonthClose":18.9,"prevQuarterClose":14.7,"fiveDayClose":17.08,"twentyDayClose":22.15,"sixtyDayClose":14.5},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MRNY\",params:#limit:5,,,undefined,":[{"date":"2026-02-19","symbol":"MRNY","amount":0.3174,"announcedDate":"2026-02-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-19","defaultRemindTime":1771511400000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-20","payableDate":"2026-02-19","currency":"USD","dateTimestamp":1771477200000,"payDate":"2026-02-20"},{"date":"2026-02-12","symbol":"MRNY","amount":0.3473,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-12","defaultRemindTime":1770906600000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-13","payableDate":"2026-02-12","currency":"USD","dateTimestamp":1770872400000,"payDate":"2026-02-13"},{"date":"2026-02-05","symbol":"MRNY","amount":0.2662,"announcedDate":"2026-02-04","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-02-05","defaultRemindTime":1770301800000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-06","payableDate":"2026-02-05","currency":"USD","dateTimestamp":1770267600000,"payDate":"2026-02-06"},{"date":"2026-01-29","symbol":"MRNY","amount":0.4791,"announcedDate":"2026-01-28","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-29","defaultRemindTime":1769697000000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-30","payableDate":"2026-01-29","currency":"USD","dateTimestamp":1769662800000,"payDate":"2026-01-30"},{"date":"2026-01-22","symbol":"MRNY","amount":0.3737,"announcedDate":"2026-01-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-01-22","defaultRemindTime":1769092200000,"name":"MRNA期权收益策略ETF-YieldMax","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-01-23","payableDate":"2026-01-22","currency":"USD","dateTimestamp":1769058000000,"payDate":"2026-01-23"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MRNY\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-07","recordDate":"2023-12-08","paymentDate":"2023-12-13","value":0.413,"currency":"USD"},{"executeDate":"2024-01-05","recordDate":"2024-01-08","paymentDate":"2024-01-09","value":2.6542,"currency":"USD"},{"executeDate":"2024-02-07","recordDate":"2024-02-08","paymentDate":"2024-02-09","value":0.5944,"currency":"USD"},{"executeDate":"2024-03-06","recordDate":"2024-03-07","paymentDate":"2024-03-08","value":1.131,"currency":"USD"},{"executeDate":"2024-04-04","recordDate":"2024-04-05","paymentDate":"2024-04-08","value":0.7832,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MRNY\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MRNY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612287922","title":"BioNTech控告Moderna侵犯新冠疫苗專利","url":"https://stock-news.laohu8.com/highlight/detail?id=2612287922","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612287922?lang=zh_tw&edition=fundamental","pubTime":"2026-02-20 03:26","pubTimestamp":1771529160,"startTime":"0","endTime":"0","summary":"德国生物制药公司BioNTech周四在特拉华州联邦法院起诉Moderna,指控Moderna的新冠疫苗 mNEXSPIKE侵犯了BioNTech和辉瑞公司的竞争性疫苗Comirnaty的相关专利。 该诉讼称,Moderna公司于2025年获得美国食品药品管理局批准的下一代新冠疫苗mNEXSPIKE,侵犯了BioNTech公司在用于简化mRNA疫苗设计的技术方面的权利,该技术允许以较低剂量为患者接种。 Moderna在2022年起诉BioNTech及其合作伙伴辉瑞公司侵犯了Comirnaty的专利权,目前诉讼仍在进行中。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-02-20/doc-inhnkyhw6558658.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BNTX","MRNA","MRNX","MRNY"],"gpt_icon":1},{"id":"1102127485","title":"異動解讀 | FDA立場轉變改善流感疫苗監管前景,Moderna盤中大漲5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102127485","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102127485?lang=zh_tw&edition=fundamental","pubTime":"2026-02-20 02:59","pubTimestamp":1771527578,"startTime":"0","endTime":"0","summary":"Moderna, Inc. 今日盘中股价大幅上涨5.06%,引起了市场的广泛关注。消息面上,美国食品和药物管理局改变了方针,将审查Moderna新型流感疫苗mRNA-1010的修订申请。此前一周,FDA曾拒绝了该疫苗的申请,引发了市场担忧,而此次立场的迅速反转显著改善了该疫苗的监管前景。多家券商随即更新了观点,其中William Blair将Moderna流感疫苗获得监管成功的概率从10%大幅提高到55%。RBC Capital Markets认为,FDA的迅速反转符合当前政策模式。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNY","MRNA","MRNX"],"gpt_icon":0},{"id":"1179667827","title":"異動解讀 | FDA同意審查流感疫苗,Moderna盤前大漲5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179667827","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179667827?lang=zh_tw&edition=fundamental","pubTime":"2026-02-18 20:39","pubTimestamp":1771418340,"startTime":"0","endTime":"0","summary":"Moderna, Inc. (MRNA) 今日盘前股价大幅上涨5.28%,引起了市场的广泛关注。消息面上,美国食品和药物管理局(FDA)已同意对Moderna公司的季节性流感疫苗mRNA-1010进行审查。此前,FDA曾以试验设计存在缺陷为由拒绝了审查申请,而此次公司提交了修改后的方案,寻求全面批准该疫苗用于50至64岁人群,并加速批准用于65岁及以上人群,同时承诺在上市后进行额外的研究。这一监管进展被视为公司产品管线推进的重要一步。如果获得批准,该疫苗最早可能在2026/27年流感季节上市,为Moderna带来新的增长动力。欧洲、加拿大和澳大利亚的监管机构也在同步审查该候选疫苗。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNX","MRNY","MRNA"],"gpt_icon":0},{"id":"2612946448","title":"Moderna(MRNA.US):美國食品藥品監督管理局將啓動對其在研季節性流感疫苗申報的審查。","url":"https://stock-news.laohu8.com/highlight/detail?id=2612946448","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612946448?lang=zh_tw&edition=fundamental","pubTime":"2026-02-18 20:04","pubTimestamp":1771416243,"startTime":"0","endTime":"0","summary":"","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4585","MRNY","BK4501","BK4568","BK4534","BK4533","BK4532","BK4551","BK4588","MRNX","MRNA","BK4139","BK4548"],"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":8,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/MRNY\",params:#limit:6,delay:false,,,undefined,":[]}}